Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies (Q43864374)

27 November 2017

title

Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies (English)

1 reference

27 November 2017

1 reference

27 November 2017

Devine S

1 reference

27 November 2017

Wickrema A

1 reference

27 November 2017

Jessop E

1 reference

27 November 2017

Amin K

1 reference

27 November 2017

Yassine M

1 reference

27 November 2017

Maynard V

1 reference

27 November 2017

Stock W

1 reference

27 November 2017

Peace D

1 reference

27 November 2017

Ravandi F

1 reference

27 November 2017

Chen YH

1 reference

27 November 2017

Hoffman R

1 reference

27 November 2017

Sossman J

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bone Marrow Transplantation

27 November 2017

published in

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

471-476

1 reference

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

High-dose intravenous melphalan: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

The systemic administration of intravenous melphalan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Acute left ventricular failure following melphalan and fludarabine conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Mechanisms of lung injury after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

7 January 2021

CYCLOSPORIN INTERACTION WITH KETOCONAZOLE AND MELPHALAN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

7 January 2021

High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704166

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704166

1 reference

Dimensions Publication ID

27 November 2017

1036759008

0 references

Fatcat ID

release_faqstk7o3zgwlbpfipsmandp6q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/faqstk7o3zgwlbpfipsmandp6q

24 November 2022

mapped directly with Wikidata item

1 reference